ANAVEX-1066

N/A

Report date: 2024/11/20 11:27:30
NME

Base Information

Drug NameANAVEX-1066
Drug Alias NameANAVEX-1066
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Actionδ-opioid receptor modulatorsSodium channels modulators
Targetsδ-opioid receptorSodium channels
Therapy Area/IndicationsVisceral PainNeuralgia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAnavex Life Sciences Corp
China Registration ClassN/A

Develop Information

Active CompaniesAnavex Life Sciences Corp
Inactive CompaniesN/A
Active IndicationsVisceral PainNeuralgia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A